Effects of dexpanthenol with or without Aloe vera extract on radiation-induced oral mucositis: Preclinical studies

International Journal of Radiation Biology

Volumn 81, Issue 3, 2005, Pages 243-250

  Dörr, Wolfgang ^a   Schlichting, S ^a   Bray, M A ^b   Flockhart, I R ^c   Hopewell, J W ^d  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b Repacel Limited   (United Kingdom)

^c Applied Analysis   (United Kingdom)

^d CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

Dexpanthenol Aloe vera; Mouse tongue mucosa; Oral mucositis; Radiotherapy; Supportive care

Indexed keywords

ALOE VERA EXTRACT; ALPHA TOCOPHEROL; ASCORBYL PALMITATE; CARBOPOL 974P; DEXPANTHENOL; GLYCEROL; RETINOL PALMITATE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG FORMULATION; INCIDENCE; MAXIMUM LIKELIHOOD METHOD; MOUSE; MOUTH ULCER; MUCOSA INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIATION PROTECTION; STATISTICAL ANALYSIS; TONGUE; TREATMENT OUTCOME;

ALOE; ANIMALS; FEMALE; MALE; MICE; MICE, INBRED C3H; MOUTH MUCOSA; PANTOTHENIC ACID; PLANT EXTRACTS; RADIATION DOSAGE; STOMATITIS;

ALOE VERA; ANIMALIA;

EID: 21344441235     PISSN: 09553002     EISSN: None     Source Type: Journal    
DOI: 10.1080/09553000500103033     Document Type: Article

References (51)

1. Antonadu D, Pepelassi M, Synodinou M, Puglisi M, Throuvalas M. 2002. Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer. Int J Radiat Oncol Biol Phys 52:739-747.
2. Bentzen SM, Saunders MI, Dische S, Bond JS. 2001. Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial. Radiother Oncol 60:123-135.
3. Bernier J, Thames HD, Smith CD, Horiot JC. 1998. Tumor response, mucosal reactions and late effects after conventional and hyperfractionated radiotherapy. Radiother Oncol 47:137-143.
4. Brizel DM, Herman T, Goffinet D, Sailer S, Agarwala S, Schwanz G et al. 2001. A phase I/II trial of escalating doses of recombinant human keratinocyte growth factor (rHuKGF) in head and neck cancer (HNC) patients receiving radiotherapy (RT) with concurrent chemotherapy (CCT), Int J Radiat Oncol Biol Phys 51(Suppl. 1):40 (Abstract).
5. Bourhis J, Etessami A, Wilbault P, Lusinchi A, Calais G, Lapeyre M et al. 2004. Altered fractionated radiotherapy in the management of head and neck carcinomas: advantages and limitations. Curr Opin Oncol 16:215-219.
6. Denham JW, Peters LJ, Johansen J, Poulsen M, Lamb DS, Hindley A et al. 1999. Do acute mucosal reactions lead to consequential late reactions in patients with head and neck cancer? adiother Oncol 52:157-164.
7. Dobrowski W, Naude J. 2000. Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancers. Radiother Oncol 57:119-124.
8. Dörr W. 1997. Three A's of repopulation during fractionated irradiation of squamous epithelia: Asymmetry loss, Acceleration of stem-cell divisions and Abortive divisions. Int J Radiat Biol 72:635-643.
9. Dörr W. 2003a. Oral mucosa: Response modification by keratinocyte growth factor, in Nieder C, Milas L, Ang KK, editors. Biological Modification of Radiation Response. Berlin, Heidelberg, New York: Springer, pp 113-122.
10. Dörr W. 2003b. Modulation of repopulation processes in oral mucosa: experimental results. Int J Radiat Biol 79:531-537.
11. Dörr W, Kummermehr J. 1990. Accelerated repopulation of mouse tongue epithelium during fractionated irradiations or following single doses. Radiother Oncol 17:249-259.
12. Dörr W, Breitner A, Kummermehr J. 1993. Capacity and kinetics of SLD repair in mouse tongue epithelium. Radiother Oncol 27:36-45.
13. Dörr W, Emmendörfer H, Haide E, Kummermehr J. 1994. Proliferation equivalent of 'accelerated repopulation' in mouse oral mucosa. Int J Radiat Biol 66:157-167.
14. Dörr W, Brankovic K, Hartmann B. 2000. Repopulation in mouse oral mucosa: changes in the effect of dose fractionation. Int J Radiat Biol 76:383-390.
15. Dörr W, Hendry JH. 2001. Consequential late effects in normal tissues. Radiother Oncol 61:223-231.
16. Dörr W, Noack R, Spekl K, Farrell CL. 2001. Modification of oral mucositis by keratinocyte growth factor: single radiation exposure. Int J Radiat Biol 77:341-347.
17. Dörr W, Spekl K, Farrell CL. 2002. Amelioration of acute oral mucositis by keratinocyte growth factor: Fractionated irradiation. Int J Radiat Oncol Biol Phys 245-251.
18. Dörr W, Heider K, Spekl K: 2004. Reduction of oral mucositis by keratinocyte growth factor: Dose-effect of KGF. Intl J Rad Biol submitted.
19. Dörr W, Dörr E, Herrman Th. 2005. Einflus der Mundpflege mit Dexpanthenol auf die Ausprägung und klinischen. Konsequenzen der radiogenen Mukositis enoralis. Exp Strahlenther Klin Strahlenbiol 14:91-94.
20. Dworacek H. 1953. Bepanthen as a protective remedy in roentgen lesions of the skin. Strahlentherapie 91:643-646.
21. Guttenberger R, Feng Y, Hunter N, Ang KK, Price R. 1991. Effects of TGF-x on radiation response in lip and jejunal mucosa in mice. In Chapman JD, Dewey WC, Whitmore GF, editors. Radiation Research: A twentieth-century perspective. Vol. I. San Diego, New York, Boston: Academic Press, p 151 (Abstract).
22. Horiot JC, Bontemps P, Van Den Bogaert W, Le Fur R, Van Den Weijngaert D, Bolla M, et al. 1997. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. Radiother Oncology 44:111-121.
23. Jackson SM, Weir LM, Hay JH, Tsang VH, Durham JS. 1997. A randomised trial of accelerated versus conventional radiotherapy in head and neck cancer. Radiother Oncol 43:39-46.
24. Kaanders JHAM, Pop LAM, Marres HAM, Bruaset I, Van Den Hoogen FJA, Merkx MAW et al. 2002. ARCON. Experience in 215 patients with advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 52:769-778.
25. Köstler WJ, Hejna M, Wenzel C, Zielinski CC. 2001. Oral mucositis complicating chemotherapy and/or radiotherapy: options for prevention and treatment. Ca Can J Clin 51:290-315.
26. Maciejewski B, Withers HR, Taylor JM, Hliniak A. 1990. Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx. Part 2. Normal tissue responses: acute and late effects. Int J Radiat Oncol Biol Phys 18:101-111.
27. Maciejewski B, Skladowski K, Pilecki B, Taylor JM, Withers RH, Miszczyk L et al. 1996. Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer. Preliminary report on acute toxicity. Radiother Oncol 40:137-145.
28. Matanic V. 1962. Die Behandlung der Geschwüre der Epidermis mit Panthenol. Z Haut Geschlech 32:240-246.
29. National Cancer Institute 2003. Common Terminology Criteria for Adverse Events v3.0 (CTCAE), NIH Publication #03-5410.
30. Neuberger F, Moritsch E. 1955. Bepanthen als Strahlenschutz der Schleimhaut. Monatsschr Ohrenheil 89:141-143.
31. Nickstadt T. 2000. Capacity and kinetics of recovery from sublethal radiation damage in oral mucosa (mouse) after irradiation with 200 kV X-rays. Doctoral Thesis (Diss. med. dent.), University of Technology Dresden.
32. Pabst S, Spekl K, Dörr W. 2004. Changes in the effect of dose fractionation during daily fractionated irradiation: studies in mouse oral mucosa. Int J Radiat Oncol Biol Phys 58:485-492.
33. Peterman A, Cella D, Glandon G, Dobrez D, Yount S. 2001. Mucositis in head and neck cancer: economic and qualiry-of-life outcomes. J Natl Cancer Inst Monograph 29:45-51.
34. Plevová P. 1999. Prevention and treatment of chemotherapy- and radiotherapy-induced oral mucositis: a review. Oral Oncol 35:453-470.
35. Potten CS, Owen G, Hewirt D, Chadwick CA, Hendry H, Lord BI, Woolford LB. 1995. Stimulation and inhibition of proliferation in the small intestineal crypts of the mouse after in vivo administration of growth factors. Gut 36:864-873.
36. Riesenbeck D, Dörr W. 1998. Documentation of radiation-induced oral mucositis: Scoring systems. Strahlenther Onkol 174(Suppl. III):44-46.
37. Roberts DB, Travis EL. 1995. Acemannan-containing wound dressing gel reduces radiation-induced skin reactions in C3H mice. Int J Radiat Oncol Biol Phys 32:1047-1052.
38. SAS Institute Inc. 1990. SAS/STAT Users Guide Version 6. Cary, NC.
39. Seegenschmiedt MH. 1998. Nebenwirkungen in der Onkologie. Berlin, Heidelberg, New York: Springer.
40. Sonis ST, Costa JWJ, Evirts SM, Lindquist LE, Nicolson M. 1992. Effect of epidermal growth factor on ulcerative mucositis in hamsters that receive cancer chemotherapy. Oral Surg Oral Med Oral Pathol 74:749-755.
41. Sonis ST, Lindquist L, Van Vugt A, Stewart AA, Stam K, Qu GY, Iwata KK, Haley JD. 1994, Prevention of chemotherapy-induced ulcerative mucositis by transforming growth factor beta 3. Cancer Res 54:1135-1138.
42. Spielberger RT, Stiff P, Emmanoulides C, Yanovich S, Bensinger W, Hedrick E, et al. 2001. Efficacy of recombinant human Keratinocyte Growth Factor (rHuKGF) in reducing mucositis in patients with hematologic malignancies undergoing autologous peripheral blood progenitor cell transplantation (auto-PBPCT) after radiation-based conditioning - results of a phase 2 trial. J Clin Oncol 20:7 (Abstract 25).
43. Spielberger RT, Emmanouilides C, Stiff W, Bensinger W, Gentile T, Weisdorf D, et al. 2003. Use of recombinant human keratinocyte growth factor (rHuGFF) can reduce severe oral mucositis in patients (pts) with hematologic malignancies undergoing autologous peripheral blood progenitor cell transplantation (auto-PBPCT) after radiation-based conditioning - results of a phase 3 trial. Proc Am Soc Clin Oncol (Abstract 3642).
44. Szórády I, Gazdag I, Kocsor S. 1966. Weitere Beobachtungen zum strahlenprotektiven Effekt von Pantothensäure. Naturwissenschaften 53:527.
45. Tarnawski R, Fowler J, Skladowski K, Swiernak A, Suwinski R, Maciejewski B, et al. 2002. How fast is repopulation of tumour cells during the treatment gap? International J Radiat Oncol Biol Phys 54:229-236.
46. Trotti A. 1998. Toxicity antagonists in head and neck cancer. Sem Radiat Oncol 8:282-291.
47. Trotti A. 2000. Toxicity in head and neck cancer: a review of trends and issues. Int J Radiati Oncol Biol Phys 47:1-12.
48. Vellkay L. 1956. Die Beeinflussung der Röntgenstrahlen-Reaktion der Haut in der gynäkologischen Strahlenpraxis durch Panthenol. Wien Med Wochenschr 106:461-462.
49. Williams MS, Burk M, Loprinzi CL, Hill M, Schomberg PJ, Nearhood K, et al. 1996. Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity. Int J Radiat Oncol Biol Phys 36:345-349.
50. Zaghloul MS, Done MJ, Kallman RF. 1994. Interleukin 1 increases thymidine labeling index of normal tissues of mice but not the tumor. Int J Radiat Oncol Biol Phys 29:805-811.
51. Zimmermann JS, Wilhelm R, Niehoff O, Schneider R, Kovacs G, Kimmig B. 1998, Prevention and therapy of acute radiation injuries of the skin and mucosa. I. Results of a German multicenter questionnaire. Strahlenther Onkol, 174:142-148.